VERTEX PHARMACEUTICALS INC (VRTX)       279.87  -3.58 (-1.26%)

279.87  -3.58 (-1.26%)

US92532F1003 - Common Stock

VERTEX PHARMACEUTICALS INC279.87

NASDAQ:VRTX (9/26/2022, 11:30:07 AM)-3.58 (-1.26%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-04 2022-08-04/amc Earnings (Next) 10-31 2022-10-31
Ins Owners 0.18% Inst Owners 91.93%
Market Cap 71.78B Shares 256.46M
PE 19.92 Fwd PE 17.73
Dividend Yield N/A Analysts 78.92
IPO 07-24 1991-07-24

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

VRTX Daily chart

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The company is headquartered in Boston, Massachusetts and currently employs 3,900 full-time employees. The firm is focused on developing medicines that treat the underlying cause of cystic fibrosis (CF) and it has several ongoing clinical and research programs to advance and extend treatment of CF. The firm's marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). Its four medicines are being used to treat the people with CF in North America, Europe and Australia. The firm has a pipeline of investigational therapies in other serious diseases where it is leveraging insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. The Company’s other pipeline products include CTX001, VX-147, VX-121, VX-561, VX-548, and VX-880.

Company Info

VERTEX PHARMACEUTICALS INC

50 Northern Avenue

Boston MASSACHUSETTS 02210

P: 16173416393.0

CEO: Reshma Kewalramani

Employees: 3900

Website: https://www.vrtx.com/

VRTX News

News Image2 days ago - Investor's Business DailyS&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market

Eli Lilly leads medical stocks setting up and showing relative strength.

News Image3 days ago - Investor's Business DailyPain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating

Pain Therapeutics sees its Relative Strength Rating enter the elite 90-plus level.

News Image3 days ago - InvestorPlace7 Growth Stocks to Buy During a Stock Market Crash

A stock market crash will only strengthen the outlook of these companies, making them good growth stocks to buy.

News Image4 days ago - ChartmillTop S&P500 movers in Thursday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

News Image7 days ago - ChartmillMonday's session: gap up and gap down stock in the S&P500 index

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

News Image7 days ago - Market News VideoBuying Power of Bitcoin vs. Vertex Pharmaceuticals at New 52-Week Low

VRTX Twits

Here you can normally see the latest stock twits on VRTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example